Joint modelling of longitudinal and competing risks data
- 29 September 2008
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 27 (30) , 6426-6438
Abstract
Available methods for joint modelling of longitudinal and survival data typically have only one failure type for the time to event outcome. We extend the methodology to allow for competing risks data. We fit a cause‐specific hazards sub‐model to allow for competing risks, with a separate latent association between longitudinal measurements and each cause of failure.The method is applied to data from the SANAD trial of anti‐epileptic drugs (AEDs), as a means of investigating the effect of drug titration on the relative effects of lamotrigine (LTG) and carbamazepine (CBZ) on treatment failure. Concern had been expressed that differential titration rates may have been to the disadvantage of CBZ. The beneficial effect of LTG on unacceptable adverse events leading to drug withdrawal did not lessen and indeed increased slightly when a calibrated dose was accounted for in the joint model. Adjustment for the titration rate of LTG relative to CBZ resulted in an unchanged effect of the former on drug withdrawals due to inadequate seizure control. LTG remains the AED of choice from this analysis. Copyright © 2008 John Wiley & Sons, Ltd.Keywords
Funding Information
- MRC (G0400615)
This publication has 23 references indexed in Scilit:
- Old versus new antiepileptic drugs: the SANAD studyThe Lancet, 2007
- Old versus new antiepileptic drugs: the SANAD studyThe Lancet, 2007
- Old versus new antiepileptic drugs: the SANAD studyThe Lancet, 2007
- Importance of competing risks in the analysis of anti-epileptic drug failureTrials, 2007
- The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trialThe Lancet, 2007
- An approach to joint analysis of longitudinal measurements and competing risks failure time dataStatistics in Medicine, 2006
- Joint models for efficient estimation in proportional hazards regression modelsStatistics in Medicine, 2003
- Identification and efficacy of longitudinal markers for survivalBiostatistics, 2002
- Jointly Modeling Longitudinal and Event Time Data With Application to Acquired Immunodeficiency SyndromeJournal of the American Statistical Association, 2001
- Modeling the Relationship of Survival to Longitudinal Data Measured with Error. Applications to Survival and CD4 Counts in Patients with AIDSJournal of the American Statistical Association, 1995